Profile
Spex Capital is a digital health and med-tech investment management firm specialized in advancing disruptive early-stage ventures to deliver breakthroughs in healthcare systems globally.
Profile
Spex Capital is a digital health and med-tech investment management firm specialized in advancing disruptive early-stage ventures to deliver breakthroughs in healthcare systems globally.
HEALTHCARE FIRST
There is today an incredible pool of talent with unexpressed potential. Many innovative ventures don’t get access to the appropriate opportunities in their early stages due to lack of funds.
We aim to bridge promising companies to help them navigate and overcome the ‘valley of death’.
HEALTHCARE FIRST
There is today an incredible pool of talent with unexpressed potential. Many innovative ventures don’t get access to the appropriate opportunities in their early stages due to lack of funds.
We aim to bridge promising companies to help them navigate and overcome the ‘valley of death’.
OUR EXPERTISE
Spex, from specere, latin verb for ‘to look at’, defines who we are.
As thorough observers, we analyse potential investee companies scrupulously, carrying out a detailed due diligence to efficiently select and invest in them.
Our aim is to overcome these global healthcare challenges:
Our impact driven reporting metrics align with the United Nations (UN) Sustainable Development Goals
We support the guidance from the Global Impact Investing Network, IRIS+ standards, and the Impact Management Project frameworks.
OUR EXPERTISE
Spex, from specere, latin verb for ‘to look at’, defines who we are.
As thorough observers, we analyse potential investee companies scrupulously, carrying out a detailed due diligence to efficiently select and invest in them.
Our aim is to overcome these global healthcare challenges:
Our impact driven reporting metrics align with the United Nations (UN) Sustainable Development Goals
We support the guidance from the Global Impact Investing Network, IRIS+ standards, and the Impact Management Project frameworks.
OUR STORY
Spex Capital started when serial health-tech entrepreneur Claudio D’Angelo decided to launch a new digital health and med-tech investment management firm.
Claudio spent considerable time and energy building relationships with partners who can help validate the target technologies and created an unparalleled network and ecosystem.
Spex brings together ambitious and innovative entrepreneurs from all walks of life who share one mission:
To make healthcare better.
Accelerating the healthcare digital revolution
OUR STORY
Spex Capital started when serial health-tech entrepreneur Claudio D’Angelo decided to launch a new digital health and med-tech investment management firm.
Claudio spent considerable time and energy building relationships with partners who can help validate the target technologies and created an unparalleled network and ecosystem.
Spex brings together ambitious and innovative entrepreneurs from all walks of life who share one mission:
To make healthcare better.
Accelerating the healthcare digital revolution
FAQs
Where do you invest?
Spex invests in digital healthcare and med-tech early stage companies.
Which criteria’s drive your investments?
We look at target companies with “traction”. That can come in the form of contracts, revenues, studies and validations, partnerships and more.
What is your investment process?
Thanks to our multidisciplinary team we are able to assess technologies from the medical standpoint and via a very detailed financial and commercial due diligence. We are planning to launch regular investment calls to attract hundreds of target companies and through a tested process, shortlist the most promising candidates.
How many investments do you make?
We aim to make up to 15 investments per annum.
Who do you partner with?
We benefit from a special partnership with the NHS - via MedCity - and with several other stakeholders in this vertical.
Which investment stages do you favour?
We offer early stage investments with the commitment to follow on with the most promising entrepreneurs up to Series A and in few cases Series B.
What is the value of your investments?
We will invest in between £500k - £2m at Seed or first ticket, up to £5m at series A or second ticket and could follow up at Series B for companies we know very well.
How are you different from other VCs?
We are specialised in digital healthcare and med-tech with an incredible flow of companies thanks to our special relationship with NHS England via MedCity. We rely heavily on an incredible panel of senior advisors with complementary experiences and expertise. SPEX also benefits from a global healthcare ecosystem via partnerships and relationships with accelerators & incubators, universities, foreign embassies, chambers of commerce, trade bodies, hospitals, payors and healthcare systems across all continents to source the highest calibre technologies worldwide.
FAQs
Where do you invest?
Spex invests in digital healthcare and med-tech early stage companies.
Which criteria’s drive your investments?
We look at target companies with “traction”. That can come in the form of contracts, revenues, studies and validations, partnerships and more.
What is your investment process?
Thanks to our multidisciplinary team we are able to assess technologies from the medical standpoint and via a very detailed financial and commercial due diligence. We are planning to launch regular investment calls to attract hundreds of target companies and through a tested process, shortlist the most promising candidates.
How many investments do you make?
We aim to make up to 15 investments per annum.
Who do you partner with?
We benefit from a special partnership with the NHS - via MedCity - and with several other stakeholders in this vertical.
Which investment stages do you favour?
We offer early stage investments with the commitment to follow on with the most promising entrepreneurs up to Series A and in few cases Series B.
What is the value of your investments?
We will invest in between £500k - £2m at Seed or first ticket, up to £5m at series A or second ticket and could follow up at Series B for companies we know very well.
How are you different from other VCs?
We are specialised in digital healthcare and med-tech with an incredible flow of companies thanks to our special relationship with NHS England via MedCity. We rely heavily on an incredible panel of senior advisors with complementary experiences and expertise. SPEX also benefits from a global healthcare ecosystem via partnerships and relationships with accelerators & incubators, universities, foreign embassies, chambers of commerce, trade bodies, hospitals, payors and healthcare systems across all continents to source the highest calibre technologies worldwide.
